Difference between revisions of "Imai Y, et al, Nature (2005), cited as Ref 21 in DOI: 10.1007/s11886-020-01293-2 (Q11015)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 436, #quickstatements; #temporary_batch_1592836326594) |
(Created claim: Page(s) (P105): 112-116, #quickstatements; #temporary_batch_1592836326594) |
||
| Property / Page(s) | |||
| + | 112-116 | ||
| Property / Page(s): 112-116 / rank | |||
| + | Normal rank | ||
Latest revision as of 14:32, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Imai Y, et al, Nature (2005), cited as Ref 21 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Angiotensin-converting enzyme 2 protects from severe acute lung failure (English)
0 references
2005
0 references
Imai Y
0 references
Kuba K
0 references
Rao S
0 references
Huan Y
0 references
Guo F
0 references
Guan B
0 references
Yang P
0 references
Sarao R
0 references
Wada T
0 references
Leong-Poi H
0 references
Nature
0 references
436
0 references
112-116
0 references
